about
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanismsMachado-Joseph Disease: from first descriptions to new perspectives.DUF1220 dosage is linearly associated with increasing severity of the three primary symptoms of autismOligonucleotide therapeutic approaches for Huntington diseaseQuantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosisMetabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersObserving Huntington's Disease: the European Huntington's Disease Network's REGISTRYUtilisation of Healthcare and Associated Services in Huntington's disease: a data mining studyConditional routing of information to the cortex: a model of the basal ganglia's role in cognitive coordinationCAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroupEmerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical ImplicationsThe P42 peptide and Peptide-based therapies for Huntington's diseaseOxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric TraitsTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesNeural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesTreatment of Huntington's disease.Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsAn Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's DiseaseIntermediate phenotypes and biomarkers of treatment outcome in major depressive disorderWhen to suspect a genetic syndromeTransgenic animal models for study of the pathogenesis of Huntington's disease and therapyFibrillogenesis of huntingtin and other glutamine containing proteinsPromise of personalized omics to precision medicine5-Hydroxymethylcytosine: A new player in brain disorders?Lithium and autophagyDeterminants of functional disability in Huntington's disease: role of cognitive and motor dysfunctionCurrent approaches to enhance glutamate transporter function and expressionPhysiological consequences of complex II inhibition for aging, disease, and the mKATP channelProtein homeostasis as a therapeutic target for diseases of protein conformationPossible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseNeural stem cells could serve as a therapeutic material for age-related neurodegenerative diseasesGenetics and neuropathology of Huntington's diseaseHeat shock transcription factor 1 as a therapeutic target in neurodegenerative diseasesLessons learned from the transgenic Huntington's disease ratsThe junctophilin family of proteins: from bench to bedsideThe N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model.Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography.Transcriptome tomography for brain analysis in the web-accessible anatomical spaceHuntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.
P2860
Q21131050-9DAEA12C-C563-46CD-9311-709FAC860B05Q21202868-C5E3D4B3-D241-4656-81AC-BA9F6D6997B1Q21563351-033A4D0C-5954-4006-B985-23314FC3DA2FQ22306293-AF367899-31E7-47D8-9549-C55EB6A8E599Q24297593-0768490C-05DE-4BAF-97BD-B3AF3098AB1CQ24562763-71CF23FF-3D98-48E6-8D62-0681AD0BD8C2Q24598264-64DBA234-984C-467E-A322-4E82CD6AF3E0Q24630195-2044D7B9-AFF0-454D-96CE-812F95B5BB3BQ24631808-D04BA2A5-C93C-41E7-881F-D5F38BF1A38EQ24644358-65EC1EFA-0EC7-4C7F-AD3D-4572B3893A23Q26744783-456A2E43-5C48-4563-AE0F-8507677480DFQ26753116-F2B92E4C-8858-40A7-A1BE-AAE0EB8DEDD2Q26764930-FEDA2900-ED0E-44C0-8031-33491B1C9227Q26768063-F680F20D-70FB-4F24-B81B-5DF96FA6444EQ26771812-0EE338C4-0DD0-44B1-8021-C8934528A9C2Q26775932-C27AB1BC-51BA-4A4F-A0C2-A7C4CCC8ACFFQ26782004-2D4437BC-5B38-4667-8DDC-2A6824A551DCQ26795417-9822C1CF-DE59-477C-B47B-B0CE3DBE28B4Q26796027-3AB9748C-7BC5-427B-A834-AFE5130EF1BEQ26823991-BEB4E541-AC04-490F-A3ED-D679E72413C1Q26830801-25C21169-097C-486F-9964-9BE25E52739FQ26849677-8AA2CA7F-7BDE-43B5-9E4A-7C5D4F2A151BQ26850062-87001467-C1A8-4058-8786-746173F53A11Q26852592-E9132690-9DA5-44FC-B1E7-C44531A25278Q26853292-8AB937DF-1E3B-4B6B-A139-EDF34F18C0A3Q26863513-64085E3E-FE36-475A-87DF-96D777D69AB2Q26866192-6C50E121-ECE1-4EDD-AA10-25F9E5DD5043Q26996723-0B3ED446-EBBA-4645-B914-878091CC1AD0Q27002338-FA1BF430-E2A0-405A-9138-D455C73A90E0Q27003283-1AFC4424-F415-4045-8FEC-7432218EAAF6Q27011417-FDAF56A5-9468-451A-8DB3-B14EE23C9A80Q27021719-3FC28A66-4407-425B-9AF8-13F424661FA4Q27023050-57583ECC-17C6-4DC4-AFA7-BD8BBF09ACB7Q27026884-475B994D-F08B-4FA5-BD2C-17DA9CFF5EBCQ27027178-0CD532DD-2155-404F-8557-BAFBD6E7EFDFQ27027609-1AD49C48-106F-4627-9872-C32798DCB861Q27301298-2E2324EE-1A7F-4446-973F-A3CB87FA6746Q27312503-2C1BEDCA-4F07-459D-AF00-405A32768396Q27318251-2FE5CC8C-FC17-4E6D-B872-55653C0FBF55Q27318766-13DC934C-CDC7-4BAF-898A-40ED524A9099
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Huntington's disease
@ast
Huntington's disease
@en
Huntington's disease
@nl
type
label
Huntington's disease
@ast
Huntington's disease
@en
Huntington's disease
@nl
prefLabel
Huntington's disease
@ast
Huntington's disease
@en
Huntington's disease
@nl
P3181
P1433
P1476
Huntington's disease
@en
P2093
Francis O Walker
P304
P3181
P356
10.1016/S0140-6736(07)60111-1
P407
P577
2007-01-01T00:00:00Z